Table 1.
1990–2021 Global and regional prevalence trends in total cardiomyopathy burden.
Fig 1.
Trends in prevalence, incidence, deaths, and disability-adjusted life-years from 1990 to 2021.
(A) Total cardiomyopathy. (B) Alcoholic cardiomyopathy. (C) Other cardiomyopathy.
Table 2.
1990–2021 Global and regional mortality trends in total cardiomyopathy burden.
Table 3.
1990–2021 Global and regional DALYs trends in total cardiomyopathy burden.
Fig 2.
The age-specific numbers and ASRs of total cardiomyopathy by SDI regions in 2021.
(A) ASPRs. (B) ASDRs. (C) ASR_DALYs.
Fig 3.
Socio-demographic index trends with ASRs of total cardiomyopathy in 21 GBD regions in 2021.
(A) ASPRs. (B) ASDRs. (C) ASR_DALYs.
Fig 4.
Contribution of alcoholic cardiomyopathy and other cardiomyopathy to total cardiomyopathy prevalence, deaths, and DALYs, both sexes, globally and by region, in 1990 and 2021.
(A) 1990 prevalence. (B) 1990 deaths. (C) 1990 DALYs. (D) 2021 prevalence. (E) 2021 deaths. (F) 2021 DALYs.
Fig 5.
ASRs of total cardiomyopathy in 204 countries and territories in 2021.
(A) ASPRs. (B) ASDRs. (C) ASR_DALYs.
Fig 6.
Socio-demographic index trends with ASRs of total cardiomyopathy in 204 countries and territories in 2021.
(A) ASPRs. (B) ASDRs. (C) ASR_DALYs.
Fig 7.
Percentage of ASDRs and ASR_DALYs attributable to risk factors (low temperature and high temperature) in global and 21 GBD regions in 2021.
(A) Total cardiomyopathy. (B) Alcoholic cardiomyopathy. (C) Other cardiomyopathy.
Fig 8.
Global disease trends predictions of total cardiomyopathy from 2021 to 2040.
(A) ASPRs. (B) ASDRs. (C) ASR_DALYs.